Literature DB >> 16338172

Membrane complement regulatory proteins.

David D Kim1, Wen-Chao Song.   

Abstract

A number of proteins anchored on the cell surface function to protect host tissues from bystander injury when complement is activated. In humans, they include decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), complement receptor 1 (CR1, CD35) and CD59. Although disease conditions directly attributable to abnormal function of these proteins are relatively rare, it has become evident from recent studies using animal models that membrane complement regulatory proteins are important modulators of tissue injury in many autoimmune and inflammatory disease settings. Evidence is also emerging to support a role of these proteins in regulating cellular immunity. In this article, we highlight recent advances on the in vivo biology of membrane complement regulatory proteins and discuss their relevance in human disease pathogenesis and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338172     DOI: 10.1016/j.clim.2005.10.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  136 in total

1.  RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival.

Authors:  Candy N Lee; Jenny L Heidbrink; Katherine McKinnon; Victoria Bushman; Henrik Olsen; William FitzHugh; Aiqun Li; Karen Van Orden; Tao He; Steven M Ruben; Paul A Moore
Journal:  Pancreas       Date:  2012-01       Impact factor: 3.327

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

Review 3.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

Review 4.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 5.  Is complement good or bad for cancer patients? A new perspective on an old dilemma.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Trends Immunol       Date:  2009-05-08       Impact factor: 16.687

6.  Upregulation of CD59: potential mechanism of accommodation in a large animal model.

Authors:  Adam D Griesemer; Masayoshi Okumi; Akira Shimizu; Shannon Moran; Yoshinori Ishikawa; Justin Iorio; J Scott Arn; Kazuhiko Yamada
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

7.  Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.

Authors:  Jie Tian; Zhili Xu; Jeffrey S Smith; Sean E Hofherr; Michael A Barry; Andrew P Byrnes
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome.

Authors:  Claudia A McDonald; Jane Y Yang; Vinita Marathe; Ten-Yang Yen; Bruce A Macher
Journal:  Mol Cell Proteomics       Date:  2008-10-15       Impact factor: 5.911

9.  A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.

Authors:  Kathryn R Girard-Pierce; Sean R Stowell; Nicole H Smith; C Maridith Arthur; Harold C Sullivan; Jeanne E Hendrickson; James C Zimring
Journal:  Blood       Date:  2013-07-22       Impact factor: 22.113

10.  Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  J Gene Med       Date:  2015 Jun-Jul       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.